- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Symphogen A/S
Headquarters: Ballerup, Denmark
Website: N/A
Year Founded: 2000
Status: Acquired
BioCentury | Jan 29, 2025
Management Tracks
Lyndra names Adam Sayer president and CEO
Plus: Martin Olin becomes CEO of Swarm, and updates from Totus, Nmdp and Vortex
BioCentury | May 13, 2021
Management Tracks
Booth joins Crescendo as CFO; plus Pharvaris, Capsida, Vaccibody, Medicenna and more
Michael Booth joined bispecifics play Crescendo Biologics Ltd. as CFO. Booth was previously division VP of investor relations and corporate responsibility at Incyte Corp. (NASDAQ:INCY).
BioCentury | Jan 29, 2021
Product Development
Servier’s American cancer experiment
How Servier has built out its cancer capabilities and U.S. presence
BioCentury | Apr 3, 2020
Deals
Servier adds mAb platform via takeout of former European biotech darling Symphogen
BioCentury | Sep 3, 2019
Company News
Management tracks: Tempus brings on former FDA chief of staff; plus Bayer, Genfit, Accent and more
BioCentury | May 15, 2019
Financial News
May 15 Financial Quick Takes: Perceptive leads $60M round for ArcherDx; plus Applied Therapeutics’ IPO, IsoPlexis, Symphogen
BioCentury | Jun 14, 2018
Tools & Techniques
Imaging immunotherapy
How a new PET agent could predict immunotherapy responses sooner
Items per page:
1 - 10 of 96